Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
7,317,782
-
Share change
-
-437,279
-
Total reported value
-
$73,712,000
-
Price per share
-
$10.07
-
Number of holders
-
35
-
Value change
-
+$174,503
-
Number of buys
-
21
-
Number of sells
-
15
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2014
As of 31 Dec 2014,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,317,782 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, JPMORGAN CHASE & CO, venBio Select Advisor LLC, VANGUARD GROUP INC, Talkot Capital, LLC, BlackRock Institutional Trust Company, N.A., BAIRD ROBERT W & CO INC /WI/, CAM Group Holding A/S, DEUTSCHE BANK AG\, and Tekla Capital Management LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.